Ruprecht Nitschke

1.2k total citations
26 papers, 838 citations indexed

About

Ruprecht Nitschke is a scholar working on Pediatrics, Perinatology and Child Health, Neurology and Molecular Biology. According to data from OpenAlex, Ruprecht Nitschke has authored 26 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 9 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Ruprecht Nitschke's work include Neuroblastoma Research and Treatments (9 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Ruprecht Nitschke is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Ruprecht Nitschke collaborates with scholars based in United States, Canada and Netherlands. Ruprecht Nitschke's co-authors include Charles B. Pratt, Mark L. Bernstein, Charles L. Sexauer, Michael B. Harris, Robert P. Castleberry, James M. Sullivan, Jonathan J. Shuster, John B. Bodensteiner, E. Ide Smith and Kenneth A. Starling and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Ruprecht Nitschke

25 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruprecht Nitschke United States 16 319 255 238 176 164 26 838
Judith K. Sato United States 16 203 0.6× 229 0.9× 310 1.3× 176 1.0× 122 0.7× 28 803
K. K. Matthay United States 11 279 0.9× 217 0.9× 109 0.5× 117 0.7× 102 0.6× 26 630
Elizabeth I. Thompson United States 20 281 0.9× 145 0.6× 605 2.5× 255 1.4× 281 1.7× 36 1.3k
S Bagnulo Italy 13 338 1.1× 183 0.7× 104 0.4× 64 0.4× 108 0.7× 23 633
H.H. Lucraft United Kingdom 18 208 0.7× 81 0.3× 182 0.8× 350 2.0× 92 0.6× 37 1.0k
Bleyer Wa United States 12 134 0.4× 91 0.4× 279 1.2× 168 1.0× 128 0.8× 18 704
F. Breatnach Ireland 14 110 0.3× 204 0.8× 154 0.6× 71 0.4× 110 0.7× 25 512
J Ochs United States 11 187 0.6× 229 0.9× 529 2.2× 386 2.2× 375 2.3× 19 1.3k
John W. Cullen United States 18 268 0.8× 166 0.7× 326 1.4× 109 0.6× 104 0.6× 29 1.1k
Archie Bleyer United States 11 92 0.3× 150 0.6× 129 0.5× 231 1.3× 338 2.1× 22 883

Countries citing papers authored by Ruprecht Nitschke

Since Specialization
Citations

This map shows the geographic impact of Ruprecht Nitschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruprecht Nitschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruprecht Nitschke more than expected).

Fields of papers citing papers by Ruprecht Nitschke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruprecht Nitschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruprecht Nitschke. The network helps show where Ruprecht Nitschke may publish in the future.

Co-authorship network of co-authors of Ruprecht Nitschke

This figure shows the co-authorship network connecting the top 25 collaborators of Ruprecht Nitschke. A scholar is included among the top collaborators of Ruprecht Nitschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruprecht Nitschke. Ruprecht Nitschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niethammer, D., et al.. (2012). Speaking Honestly with Sick and Dying Children and Adolescents: Unlocking the Silence. Medical Entomology and Zoology. 1 indexed citations
2.
Nitschke, Ruprecht, et al.. (2000). Care of terminally ill children with cancer. Medical and Pediatric Oncology. 34(4). 268–270. 33 indexed citations
3.
Nitschke, Ruprecht, et al.. (1998). Topotecan in Pediatric Patients With Recurrent and Progressive Solid Tumors. Journal of Pediatric Hematology/Oncology. 20(4). 315–318. 121 indexed citations
4.
McWilliams, Nancy B., F. Ann Hayes, A. A. Green, et al.. (1995). Cyclophosphamide/doxorubicin vs. Cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: A pediatric oncology group randomized phase II study. Medical and Pediatric Oncology. 24(3). 176–180. 18 indexed citations
5.
Castleberry, Robert P., Peter D. Emanuel, Kenneth S. Zuckerman, et al.. (1994). A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia. New England Journal of Medicine. 331(25). 1680–1684. 77 indexed citations
6.
Kung, Faith, Charles B. Pratt, Roger A. Vega, et al.. (1993). Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A pediatric oncology group phase II study. Cancer. 71(5). 1898–1903. 87 indexed citations
7.
Shuster, Jonathan J., Nancy B. McWilliams, Robert P. Castleberry, et al.. (1992). Serum Lactate Dehydrogenase in Childhood Neuroblastoma A Pediatric Oncology Group Recursive Partitioning Study. American Journal of Clinical Oncology. 15(4). 295–303. 57 indexed citations
8.
Kaufman, Keith L., et al.. (1992). The Availability of Psychosocial Interventions to Children With Cancer and Their Families. Children s Health Care. 21(1). 21–25. 8 indexed citations
9.
Vats, Tribhawan S., George R. Buchanan, Paulette Mehta, et al.. (1992). A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. Investigational New Drugs. 10(3). 231–234. 9 indexed citations
10.
Joshi, Vijay, Alan Cantor, Geoffrey Altshuler, et al.. (1992). Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the pediatric oncology group. Cancer. 69(8). 2197–2211. 80 indexed citations
11.
Nitschke, Ruprecht, Charles B. Pratt, Michael B. Harris, et al.. (1992). Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. Investigational New Drugs. 10(2). 93–96. 4 indexed citations
12.
Bodensteiner, John B., et al.. (1989). Reversible Treatment-Related Leukoencephalopathy. Journal of Child Neurology. 4(3). 208–213. 22 indexed citations
13.
14.
Nitschke, Ruprecht, G. Bennett Humphrey, Charles L. Sexauer, & E. Ide Smith. (1983). Neuroblastoma: Therapy for infants with good prognosis. Medical and Pediatric Oncology. 11(3). 154–158. 11 indexed citations
15.
Olmsted, Richard W., et al.. (1982). Therapeutic choices made by patients with end-stage cancer. The Journal of Pediatrics. 101(3). 471–476. 57 indexed citations
16.
Buchanan, George R., Sylvia S. Bottomley, & Ruprecht Nitschke. (1978). 582 Δ-AMINOLEVULINIC ACID (ALA) SYNTHETASE DEFECT IN A FEMALE WITH CONGENITAL SIDEROBLASTIC ANEMIA. Pediatric Research. 12. 460–460. 2 indexed citations
17.
18.
Nitschke, Ruprecht & Myron Karon. (1975). INHIBITORY EFFECTS OF MITOGENS ON ADENOIDAL LYMPHOCYTES IN VITRO. Cell Proliferation. 8(2). 125–134. 1 indexed citations
19.
Rivard, Georges E., José Antonio Ortega, Robert E. Hittle, Ruprecht Nitschke, & Myron Karon. (1975). Intensive chemotherapy as primary treatment for rhabdomyosarcoma of the pelvis. Cancer. 36(5). 1593–1597. 60 indexed citations
20.
Humphrey, G. Bennett, et al.. (1974). Leukemic Serum Inhibition of Phytohemagglutinin-Induced Transformation. The Journal of Immunology. 113(1). 63–69. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith K. Sato Breakdown of academic impact, for papers by K. K. Matthay Breakdown of academic impact, for papers by Elizabeth I. Thompson Breakdown of academic impact, for papers by S Bagnulo Breakdown of academic impact, for papers by H.H. Lucraft Breakdown of academic impact, for papers by Bleyer Wa Breakdown of academic impact, for papers by F. Breatnach Breakdown of academic impact, for papers by J Ochs Breakdown of academic impact, for papers by John W. Cullen Breakdown of academic impact, for papers by Archie Bleyer
Rankless by CCL
2026